MacroGenics, a biotechnology company, has reported concerning safety outcomes in its phase 2 trial of vobramitamab duocarmazine, a B7-H3-directed antibody-drug …
Insilico Medicine, a clinical-stage company specializing in AI-driven drug discovery, has shifted its corporate headquarters from New York to Boston. …
Rubedo Life Sciences, a biopharmaceutical company specializing in the development of therapies targeting senescent cells associated with age-related diseases, has …
In a collaborative effort between Brainomix, an AI-powered medical technology company, and AstraZeneca, a new study demonstrates significant advancements in …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.